<p>The clonal expansion of adoptively transferred CD4<sup>+</sup> T cells following vaginal or nasal immunization with OVA plus CpG ODN 1826 was analyzed on days 2.5, 3, 5, and 7 post immunization in draining and distal lymph nodes and spleen. Values reported in y axis indicate the percentage of proliferating antigen-specific T cells. OVA-specific T cells were identified as CD4<sup>+</sup> CFSE-positive populations, with light scatter properties of lymphocytes. The percentages of proliferating cells are shown on the <i>y</i> axis. Bars represent the means ± standard errors of the means (SEM) of values from nine mice assessed in three separate experiments.</p
<p>Splenocytes from immunized mice with PBS, BCG Wild-type, BCG WT surface decorated with Avi-OVA, B...
<p>Mice were intranasally immunized with OVA either alone (open column) or with 500 µg of PMB (close...
<p>(<b>a</b>) Ten days following immunization, total CD8<sup>+</sup> CTLs containing AdVova-specific...
<p>OVA-specific proliferation of CD4<sup>+</sup> T cells was assessed 57 hours following immunizatio...
<p>CD4+ T cells, isolated from OT-II mice, were labeled with CFSE and adoptively transferred into re...
<p>The expression of CD45RB, CD69, CD44 and CD62L was analysed as a function of cell divisions on OV...
<p>CFSE-labelled OT-II CD4<sup>+</sup> T cells were transferred into recipient C57BL/6J mice. Twenty...
Primary T-cell activation at mucosal sites is of utmost importance for the development of vaccinatio...
Primary T-cell activation at mucosal sites is of utmost importance for the development of vaccinatio...
<p>Following immunization, AdVova-specific CTLs were analyzed in the peripheral blood at different t...
<p>C57BL/6 mice were immunized by the vaginal or nasal route with OVA Alexa Fluor 647-conjugate (25 ...
<p>CD98hc<sup>f/f</sup>-CD4 or CD98hc<sup>+/+</sup>-CD4 mice were immunized with OVA protein emulsif...
<p>(A) Proportion of CD4<sup>+</sup>Foxp3<sup>+</sup> cells within T (CD3-gated) cells in mucosal (N...
<p>(A) <i>In vivo</i> immunization model with OVA-V antigen. (B, C) Proliferation of CD4+ T cells (B...
<p>(A) C57BL/6 mice were immunized subcutaneously with 100 µg of <i>C. muridarum</i> peptide (RplF<s...
<p>Splenocytes from immunized mice with PBS, BCG Wild-type, BCG WT surface decorated with Avi-OVA, B...
<p>Mice were intranasally immunized with OVA either alone (open column) or with 500 µg of PMB (close...
<p>(<b>a</b>) Ten days following immunization, total CD8<sup>+</sup> CTLs containing AdVova-specific...
<p>OVA-specific proliferation of CD4<sup>+</sup> T cells was assessed 57 hours following immunizatio...
<p>CD4+ T cells, isolated from OT-II mice, were labeled with CFSE and adoptively transferred into re...
<p>The expression of CD45RB, CD69, CD44 and CD62L was analysed as a function of cell divisions on OV...
<p>CFSE-labelled OT-II CD4<sup>+</sup> T cells were transferred into recipient C57BL/6J mice. Twenty...
Primary T-cell activation at mucosal sites is of utmost importance for the development of vaccinatio...
Primary T-cell activation at mucosal sites is of utmost importance for the development of vaccinatio...
<p>Following immunization, AdVova-specific CTLs were analyzed in the peripheral blood at different t...
<p>C57BL/6 mice were immunized by the vaginal or nasal route with OVA Alexa Fluor 647-conjugate (25 ...
<p>CD98hc<sup>f/f</sup>-CD4 or CD98hc<sup>+/+</sup>-CD4 mice were immunized with OVA protein emulsif...
<p>(A) Proportion of CD4<sup>+</sup>Foxp3<sup>+</sup> cells within T (CD3-gated) cells in mucosal (N...
<p>(A) <i>In vivo</i> immunization model with OVA-V antigen. (B, C) Proliferation of CD4+ T cells (B...
<p>(A) C57BL/6 mice were immunized subcutaneously with 100 µg of <i>C. muridarum</i> peptide (RplF<s...
<p>Splenocytes from immunized mice with PBS, BCG Wild-type, BCG WT surface decorated with Avi-OVA, B...
<p>Mice were intranasally immunized with OVA either alone (open column) or with 500 µg of PMB (close...
<p>(<b>a</b>) Ten days following immunization, total CD8<sup>+</sup> CTLs containing AdVova-specific...